Medications for Alcohol Use Disorder
JAMA · 27.10.2026 · 336 (16) · 1463
DOI: 10.1001/jama.2026.10575 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 27.10.2026. Verfasst von Stephen R Holt. Beteiligte Einrichtung: Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
This JAMA Insights examines US Food and Drug Administration–approved medications for alcohol use disorder, including the dosing, efficacy, and adverse effects of naltrexone, acamprosate, and disulfiram.
Autor:innen und Institutionen
- Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut.
Zitieren
APA
Holt, S. R. (2026). Medications for Alcohol Use Disorder. JAMA, 336(16), 1463. https://doi.org/10.1001/jama.2026.10575
Vancouver
Holt SR. Medications for Alcohol Use Disorder. JAMA. 2026;336(16):1463. doi:10.1001/jama.2026.10575
BibTeX
@article{Holt2026,
author = {Holt, Stephen R},
title = {Medications for Alcohol Use Disorder},
journal = {JAMA},
year = {2026},
volume = {336},
number = {16},
pages = {1463},
doi = {10.1001/jama.2026.10575}
}
EUVIMED